Mammalian DNA damage-inducible genes associated with growth arrest and apoptosis

Mutation Research - Reviews in Genetic Toxicology

Volumn 340, Issue 2-3, 1996, Pages 109-124

  Smith, Martin L ^a   Fornace Jr , Albert J ^a  

^a Laboratory of Leukocyte Biology   (United States)

Author keywords

Apoptosis; DNA repair; GADD45; p53

Indexed keywords

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; DNA DAMAGE; DNA REPAIR; GENE MUTATION; GENOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

ANIMALIA; MAMMALIA;

EID: 0029313915     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0165-1110(96)90043-3     Document Type: Article

References (143)

1. Aboussekhra A., Biggerstaff M., Shivji M.K.K., Vilpo J.A., Moncollin V., Podust V.N., Protic M., Hubscher U., Egly J.-M., Wood R.D. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell. 80:1995;859-868.
2. Abrahams P.J., Schouten R., van Laar T., Houweling A., Terleth C., van der Eb A.J. Different regulation of p53 stability in UV-irradiated normal and DNA repair deficient human cells. Mutation Res. 336:1995;169-180.
3. Agarwal M.L., Agarwal A., Taylor W.R., Stark G.R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA. 92:1995;8493-8497.
4. Ali-Osman F., Berger M.S., Rairkar A., Stein D.E. Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases α and β, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy. J. Cell. Biochem. 54:1994;11-19.
5. Allay J.A., Dumenco L.L., Koc O.N., Liu L., Gerson S.L. Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood. 85:1995;3342-3351.
6. Ames B.N., Gold L.S., Willett W.C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA. 92:1995;5258-5265.
7. Apte S.S., Mattei M.G., Seldin M.F., Olsen B.R. The highly conserved defender against death 1 (DAD1) gene maps to human chromosome 14q11-q12 and mouse chromosome 14 and has plant and nematode homologs. FEBS Lett. 363:1995;304-306.
8. Ayyagari R., Impellizzeri K.J., Yoder B.L., Gary S.J., Burgers P.M.J. A mutational analysis of the yeast proliferating cell nuclear antigen indicates distinct roles in DNA replication and DNA repair. Mol. Cell. Biol. 15:1995;4420-4429.
9. Bae I., Smith M.L., Fornace A.J. Jr. Induction of p53-, MDM2- and WAF1 / CIP1-like molecules in insect cells by DNA-damaging agents. Exp. Cell Res. 217:1995;541-545.
10. Bernhard E.J., McKenna W.G., Muschel R.J. Cyclin expression and G2-phase delay after irradiation. Radiat. Res. 138:1994;S64-67.
11. Brown R., Clugston C., Burns P., Edlin A., Vasey P., Vojtesek B., Kaye S.B. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int. J. Cancer. 55:1993;678-684.
12. Cailles C., Helmberg A., Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53 target genes. Nature. 370:1994;220-223.
13. Canman C.E., Wolff A.C., Chen C-Y, Fornace A.J. Jr., Kastan M.B. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 54:1994;5054-5058.
14. Canman C.E., Gilmer T.M., Coutts S.B., Kastan M.B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9:1995;600-611.
15. Canman C.E., Kastan M.B. Induction of apoptosis by tumor suppressor genes and oncogenes. Semin. Cancer Biol. 6:1995;17-25.
16. Castle V.P., Heidelberger K.P., Bromberg J., Ou X., Dole M., Nunez G. Expression of the apoptosis-suppressing protein Bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am. J. Pathol. 143:1993;1543-1550.
17. Chen C-Y, Oliner J.D., Zhan Q., Fornace A.J. Jr., Vogelstein B., Kastan M.B. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Natl. Acad. Sci. USA. 91:1994;2684-2688.
18. Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene. 1995;. (in press).
19. Chittenden T., Harrington E.A., O'Connor R., Flemington C., Lutz R.J., Evan G.I., Guild B.C. Induction of apoptosis by the Bcl-2 homolog Bak. Nature. 374:1995;733-736.
20. Chou J., Roizman B. The g.34.5 gene of herpes simplex virus I precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA. 89:1992;3266-3270.
21. Clarke A.R., Purdie C.A., Harrison D.J., Morris R.G., Bird C.C., Hooper M.L., Wyllie A.H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:1993;849-852.
22. Clarke A.R., Gledhill S., Hooper M.L., Bird C.C., Wyllie A.H. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma irradiation. Oncogene. 9:1994;1767-1773.
23. Coates P.J., Save V., Ansari B., Hall P.A. Demonstration of DNA damage/repair in individual cells using in situ end labelling, Association of p53 with sites of DNA damage. J. Pathol. 176:1995;19-26.
24. Coffer P.J., Burgering B.Mth., Peppelenbosch M.P., Bos J.L., Kruijer W. UV activation of receptor tyrosine kinase activity. Oncogene. 11:1995;561-569.
25. Columbel M., Symmans F., Gil S., O'Toole K.M., Chopin D., Benson M., Olsson C.A., Korsmeyer S., Buttyan R. Detection of the apoptosis suppressing oncoprotein Bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol. 143:1993;390-400.
26. Cox L.S., Hupp T., Midgely C.A., Lane D.P. A direct effect of activated human p53 on nuclear DNA replication. EMBO J. 14:1995;2099-2105.
27. Cross S.M., Sanchez C.A., Morgan C.A., Schimke M.K., Ramel S., Idzerda R.L., Raskind W.H., Reid B.J. A p53-dependent mouse spindle checkpoint. Science. 267:1995;1353-1356.
28. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
29. Devary Y., Gottlieb R.A., Smeal T., Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell. 71:1992;1081-1091.
30. Dole M., Nunez G., Merchant A.K., Maybaum J., Rode C.K., Bloch C.A., Castle V.P. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54:1994;3253-3259.
31. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
32. Eizenberg O., Faber-Elman A., Gottlieb E., Oren M., Rotter V., Schwarz M. Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J. 14:1995;1136-1144.
33. Elledge S.J., Davis R.W. Identification and isolation of the gene encoding the small subunit of ribonucleotide reductase from S.cerevisiae, A DNA damage inducible gene required for mitotic viability. Mol. Cell. Biol. 7:1987;2783-2793.
34. Engelberg D., Klein C., Martinetto H., Struhl K., Karin M. The UV response pathway involving the RAS signalling pathway and AP-1 transcription factors is conserved between yeast and mammals. Cell. 77:1994;381-390.
35. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
36. Ewen M.E. The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13:1994;45-66.
37. Fan S., El-Deiry W.S., Bae I., Freeman J., Jondle D., Bhatia K., Fornace A.J. Jr., Magrath I., Kohn K.W., O'Connor P.M. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 54:1994;5824-5830.
38. Fan S., Smith M.L., Rivet D.J., Duba D., Zhan Q., Kohn K.W., Fornace A.J. Jr., O'Connor P.M. Disruption of p53 function sensitizes breast cancer MCF7 cells to cisplatin and pentoxifylline. Cancer Res. 55:1995;1649-1654.
39. Fernandes-Alnemri T., Litwack G., Alnemri E.S. Mch2, a new member of the apoptotic Ced-3/Ice protease gene family. Cancer Res. 55:1995;2737-2742.
40. Fisher D.E. Apoptosis in cancer therapy, Crossing the threshold. Cell. 78:1994;539-542.
41. Fisher G.H., Rosenberg F.J., Straus S.E., Dale J.K., Middleton L.A., Lin A.Y., Strober W., Lenardo M.J., Puck J.M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 81:1995;935-946.
42. Ford J.M., Hanawalt P.C. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl. Acad. Sci. USA. 92:1995;8876-8880.
43. Fornace A.J. Jr. Mammalian genes induced by radiation, Activation of genes associated with growth control. Annu. Rev. Genet. 26:1992;507-526.
44. Fornace A.J. Jr., Zmudzka B., Hollander M.C., Wilson S.H. Induction of beta-polymerase mRNA by DNA-damaging agents in Chinese hamster ovary cells. Mol. Cell. Biol. 9:1989;851-853.
45. Friedberg E.C., Walker G.C., Siede W. DNA Repair and Mutagenesis. 1995;ASM Press, Washington, DC.
46. 6-methylguanine-DNA-methyltransferase in mammalian cells by DNA-damaging treatments. Mol. Cell. Biol. 11:1991;4660-4668.
47. Gately D.P., Jones J.A., Christen R., Barton R.M., Los G., Howell S.B. Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo. Br. J. Cancer. 70:1994;1102-1106.
48. Gotoh Y., Masuyama N., Suzuki A., Ueno N., Nishida E. Involvement of the MAP kinase cascade in Xenopus mesoderm induction. EMBO J. 14:1995;2491-2498.
49. Graeber T.G., Peterson J.F., Tsai M., Monica K., Fornace A.J. Jr., Giaccia A.J. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:1994;6264-6277.
50. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene, Clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878.
51. Haldar S., Negrini M., Monne M., Sabbioni S., Croce C.M. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 54:1994;2095-2097.
52. Hall P.A., Kearsey J.M., Coates P.J., Norman D.G., Warbrick E., Cox L.S. Characterization of the interaction between PCNA and Gadd45. Oncogene. 10:1995;2427-2433.
53. Hanabuchi S., Koyanagi M., Kawasaki A., Shinohara N., Matsuzawa A., Nishimura Y., Kobayashi Y., Yonehara S., Yagita H., Okum S. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA. 91:1994;4930-4934.
54. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-Interacting Protein Cip1 is a potent Inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
55. Hartwell L.H., Kastan M.B. Cell cycle control and cancer. Science. 266:1994;1821-1828.
56. Harvey M., Vogel H., Morris D., Bradley A., Bernstein A., Donehower L.A. A mutant p53 transgene accelerates tumor development in heterozygous but not nullizygous p53-deficient mice. Nature Genet. 9:1995;305-311.
57. Havre P.A., Yuan J., Hedrick L., Cho K.R., Glazer P.M. p53 inactivation by HPV16-E6 results in increased mutagenesis in human cells. Cancer Res. 55:1995;4420-4424.
58. Hengartner M.O., Horvitz H.R. Activation of C. elegans cell death protein Ced-9 by an amino acid substitution in a domain conserved in Bcl-2. Nature. 369:1994;318-320.
59. Herrlich P., Rahmsdorf H.J. Transcriptional and post-transcriptional responses to DNA-damaging agents. Curr. Opin. Cell Biol. 6:1994;425-431.
60. Hinds P.W. The retinoblastoma tumor suppressor protein. Curr. Opin. Genet. Dev. 5:1995;79-83.
61. Ikegaki N., Katsumata M., Minna J., Tsujimoto Y. Expression of Bcl-2 in small cell lung carcinoma cells. Cancer Res. 54:1994;6-8.
62. Jackson D.A., Hassan A.B., Errington R.J., Cook P.R. Sites in human nuclei where damage induced by ultraviolet light is repaired, localization relative to transcription sites and concentrations of proliferating cell nuclear antigen and p53. J. Cell Sci. 107:1994;1753-1760.
63. Johnson A.L., Barker D.G., Johnson L.H. Induction of yeast DNA ligase genes in exponential and stationary phase cultures in response to DNA damaging agents. Curr. Genet. 11:1986;107.
64. Johnson L.H., White J.H.M., Johnson A.L., Luccini G., Plevani P. The yeast DNA polymerase I transcript is regulated in both mitotic cell cycle and in meiosis and is also induced after DNA damage. Nucleic Acids Res. 15:1987;5017.
65. Joiner M.C. Evidence for induced radioresistance from survival and other end points, An introduction. Radiat. Res. 138:(Suppl. 1):1994;S5-8.
66. Jones C.J., Wynford-Thomas D. Is TFIIH an activator of the p53-mediated G1/S checkpoint? Trends Genet. 11:1995;165-166.
67. Karin M. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr. Opin. Cell. Biol. 6:1994;415-424.
68. Kiefer M.C., Brauer M.J., Powers V.C., Wu J.J., Umansky S.R., Tomei L.D., Barr P.J. Modulation of apoptosis by the widely distributed Bcl-2 homolog Bak. Nature. 374:1995;736-739.
69. Kastan M.B., Zhan Q., El-Deiry W.S., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., Fornace A.J. Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 71:1992;587-597.
70. Kondo S., Barnett G.H., Hara H., Morimura T., Takeuchi. Mdm2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apotosis. Oncogene. 10:1995;2001-2006.
71. Korsmeyer S.J. Regulators of cell death. Trends Genet. 11:1995;101-105.
72. 3-methyladenine glycosylase RNA transcripts in rat hepatoma cells treated with DNA-damaging agents. Biochem. Biophys. Res. Commun. 176:1991;1086-1092.
73. Lavin M.F., Schroeder A.L. Damage-resistant DNA synthesis in eucaryotes. Mutation Res. 193:1988;193-206.
74. Lee S., Elenbaas B., Levine A.J., Griffith J. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell. 81:1995;1013-1020.
75. Leek R.D., Kaklamanis L., Pezzella F., Gatter K.C., Harris A.L. Bcl-2 in normal human breast and carcinoma, association with estrogen receptor positive, epidermal growth factor receptor-negative tumors and in situ cancer. Br. J. Cancer. 69:1994;135-139.
76. Levy E., Baroche C., Barret J.M., Alapetite C., Salles B., Averbeck D., Moustacchi E. Activated ras oncogene and specifically acquired resistance to cisplatin in human mammary epithelial cells, Inductionof DNA cross-links and their repair. Carcinogenesis. 15:1994;845-850.
77. Lin H.J., Eviner V., Prendergast G.C., White E. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol. Cell. Biol. 15:1995;4536-4544.
78. Liu T.J., El-Naggar A.K., McDonnell T.J., Steck K.D., Wang M., Taylor D.L., Claymen G.L. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 55:1995;3117-3122.
79. Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 70:1992;923-935.
80. Lowe S.W., Bodis S., McClatchey A., Remington L., Ruley H.E., Fisher D.E., Housman D.E., Jacks T. P53 status and the efficacy of cancer therapy in vivo. Science. 266:1994;807-810.
81. Marcus S., Polverino A., Chang E., Robbins D., Cobb M.H., Wigler M.H. Shk1, a homolog of the Saccharomyces cerevisiae Ste20 and mammalian p65PAK kinases, is a component of a Ras/Cdc42 signalling module in the fission yeast Schizosaccharomyces pombe. Proc. Natl. Acad. Sci. USA. 92:1995;6180-6184.
82. Matijasevic Z., Boosalis M., Mackay W., Samson L., Ludlum D.B. Protection against chloroethylnitrosourea cytotoxicity by eucaryotic 3-methyladenine DNA glycosylase. Proc. Natl. Acad. Sci. USA. 90:1993;11855-11859.
83. Mayr G.A., Reed M., Wang P., Wang Y., Schwedes J.F., Tegtmeyer P. Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation. Cancer Res. 55:1995;2410-2417.
84. McCann A.H., Kirley A., Carney D.N., Corbally N., Magee H.M., Keating G., Dervan P.A. Amplification of the MDM2 gene in human breast cancer and its association with Mdm2 and p53 protein status. Br. J. Cancer. 71:1995;981-985.
85. McWhir J., Selfridge J., Harrison D.J., Squires S., Melton D.W. Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nature Genet. 5:1993;217-224.
86. Michieli P., Chedid M., Lin D., Pierce J.H., Mercer W.E., Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:1994;3391-3395.
87. Midgely C.A., Owens B., Briscoe C.V., Thomas D.B., Lane D.P., Hall P.A. Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J. Cell Sci. 108:1995;1843-1848.
88. Milner A.E., Grand R.J., Waters C.M., Gregory C.D. Apoptosis in Burkitt lymphoma cells is driven by c-myc. Oncogene. 8:1993;3385-3391.
89. Minn A.J., Rudin C.M., Boise L.H., Thompson C.B. Expression of Bcl-XL can confer a multidrug resistance phenotype. Blood. 86:1995;1903-1910.
90. Miura M., Zhu H., Rotello R., Hartweig E.A., Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 75:1993;653-660.
91. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human BAX gene. Cell. 80:1995;293-299.
92. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B., Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and BAX gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805.
93. Muschel R.J., Zhang H.B., Iliakis G., McKenna W.G. Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res. 51:1991;5113-5117.
94. Nelson W.G., Kastan M.B. DNA strand breaks, the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1994;1815-1823.
95. Nurse P. Ordering S phase and M phase in the cell cycle. Cell. 79:1994;547-550.
96. Oshita F., Yamamoto N., Fukuda M., Ohe Y., Tamura T., Eguchi K., Shinkai T., Saijo N. Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro. Cancer Res. 55:1995;2334-2337.
97. Paoletti C., et al. Inducible responses to DNA damages, CNRS symposium. Biochemie. 64:1982;541-848.
98. Paules R.S., Levedakou E.N., Wilson S.J., Innes C.L., Rhodes N., Tlsty T.D., Galloway D.A., Donehower L.A., Tainsky M.A., Kaufmann W. Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res. 55:1995;1763-1773.
99. Paulovich A.G., Hartwell L.H. A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell. 82:1995;841-847.
100. Powell S.N., DeFrank J.S., Connell P., Eogan M., Preffer F., Dombkowski D., Tang W., Friend S. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 55:1995;1643-1648.
101. Protic M., Roilides E., Levine A.S., Dixon K. Enhancement of DNA repair capacity of mammalian cells by carcinogen treatment. Somat. Cell Mol. Genet. 14:1988;351-357.
102. Reynolds J.E., Yang T., Qian L., Jenkinson J.D., Zhou P., Eastman A., Craig R.W. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-myc overexpression in Chinese hamster ovary cells. Cancer Res. 54:1994;6348-6352.
103. Ron D., Habener J.F. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant negative inhibitor of gene transcription. Genes Dev. 6:1992;439-453.
104. Rowley R., Hudson J., Young P.G. The weel protein kinase is required for radiation-induced mitotic delay. Nature. 356:1992;353-355.
105. Sands A.T., Suraokar M.B., Sanchez A., Marth J.E., Donehower L.A., Bradley A. p53 deficiency does not affect the accumulation of point mutations in a transgene target. Proc. Natl. Acad. Sci. USA. 92:1995;8517-8521.
106. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Frydman M., Harnik R., Patanjali S.R., Simmons A., Clines G.A., Sartiel A., Gatti R.A., Chessa L., Sanal O., Lavin M.F., Jaspers N.G.J., Taylor A.M.R., Arlett C.F., Miki T., Weissman S.M., Lovett M., Collins F.S., Shiloh Y. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
107. Schipper H.M., Cisse S., Stopa E.G. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37:1995;758-768.
108. Schott A.F., Apel I.J., Nunez G., Clarke M.F. BCL-XL protects cancer cells from p53-mediated apoptosis. Oncogene. 11:1995;1389-1394.
109. Sedlak T.W., Oltvai Z.N., Yang E., Wang K., Boise L.H., Thompson C.B., Korsmeyer S.J. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA. 92:1995;7834-7838.
110. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
111. Sidransky D., Mikkelsen T., Schwechheimer K., Rosenblum M.L., Cavenee W., Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature. 355:1992;846-848.
112. Siede W., Friedberg A.S., Friedberg E.C. RAD9-dependent G1 arrest defines a second checkpoint for damaged DNA in the cell cycle of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 90:1993;7985-7989.
113. Siede W., Friedberg A.S., Dianova I., Friedberg E.C. Characterization of G1 checkpoint control in the yeast Saccharomyces cerevisiae following exposure to DNA-damaging agents. Genetics. 138:1994;271-281.
114. Slebos R.J., Lee M.H., Plunkett B.S., Kessis T.D., Williams B.O., Jacks T., Hedrick L., Kastan M.B., Cho K. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA. 91:1994;5320-5324.
115. Smith M.L., Fornace A.J. Jr. Genomic instability and the role of p53 mutations in cancer cells. Curr. Opin. Oncol. 7:1995;69-75.
116. Smith M.L., Zhan Q., Bae I., Fornace A.J. Jr. Role of retinoblastoma gene product in p53-mediated DNA damage response. Exp. Cell Res. 215:1994a;386-389.
117. Smith M.L., Chen I-T., Zhan Q., Bae I., Chen C-Y, Gilmer T.M., Kastan M.B., O'Connor P.M., Fornace A.J. Jr. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science. 266:1994b;1376-1380.
118. Smith M.L., Chen I.T., Zhan Q., O'Connor P.M., Fornace A.J. Jr. Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene. 10:1995;1053-1059.
119. Stewart N., Hicks G.G., Paraskevas F., Mowat M. Evidence for a second cell cycle block at G2/M by p53. Oncogene. 10:1995;109-115.
120. Tainsky M.A., Bischoff F.Z., Strong L.C. Genomic instability due to germline p53 mutations drives preneoplastic progression toward cancer in human cells. Cancer Metastasis Rev. 14:1995;43-48.
121. Thiagalingam S., Kinzler K.W., Vogelstein B. PAK1, a gene that can regulate p53 activity in yeast. Proc. Natl. Acad. Sci. USA. 92:1995;6062-6066.
122. Tyrell R.M., Basu-Modak S. Transient enhancement of heme oxygenase-1 mRNA accumulation, A marker of oxidative stress to eukaryotic cells. Methods Enzymol. 234:1994;224-235.
123. Walker G.C. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Eschericia coli. Microbiol. Rev. 48:1984;60-93.
124. Wang L., Miura M., Bergeron L., Zhu H., Yuan J. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell. 78:1994;739-750.
125. Wang X.W., Yeh H., Schaeffer L., Roy R., Moncollin V., Egly J-M, Wang Z., Friedberg E.C., Evans M.K., Taffe B.G., Bohr V.A., Weeda G., Hoeijmakers J.H.J., Forrester K., Harris C.C. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet. 10:1995;188-195.
126. Wassarman D.A., Therrien M., Rubin G.M. The Ras signalling pathway in Drosophila. Curr. Opin. Genet. Dev. 5:1995;44-50.
127. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
128. Weinert T.A., Hartwell L.H. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science. 241:1988;317-322.
129. Weller M., Malipiero U., Aguzzi A., Reed J.C., Fontana A. Protooncogene BCL2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J. Clin. Invest. 95:1995;2633-2643.
130. White M.A., Nicollette C., Minden A., Polverino A., Van Aelst L., Karin M., Wigler M.H. Multiple Ras functions can contribute to mammalian cell transformation. Cell. 80:1995;533-541.
131. Wu X., Levine A.J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA. 91:1994;3602-3606.
132. Wyllie A.H. Death gets a brake. Nature. 369:1994;272-273.
133. Xiao Z.X., Chen J., Levine A.J., Modjtahedi N., Xing J., Sellers W.R., Livingston D.M. Interaction between the retinoblastoma protein and the oncoprotein Mdm2. Nature. 375:1995;694-698.
134. Yamaizumi M., Sugano T. UV-induced nuclear accumulation of p53 is evoked through DNA damage of actively transcribed genes independent of the cell cycle. Oncogene. 9:1994;2775-2784.
135. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285-291.
136. Yang Y., Minucci S., Ozato K., Heyman R.A., Ashwell J.D. Efficient inhibition of activation-induced Fas ligand up-regulation and T-cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J. Biol. Chem. 270:1995;18672-18677.
137. Zaidi N.H., Pretlow T.P., O'Riordan M.A., Dumenco L.L., Allay E., Gerson S.L. Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis. 16:1995;451-456.
138. Zauberman A., Lupo A., Oren M. Identification of p53 target genes through immune selection of genomic DNA, The cyclin G gene contains two distinct p53 binding sites. Oncogene. 10:1995;2361-2366.
139. Zhan Q., Carrier F., Fornace A.J. Jr. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol. 13:1993;4242-4250.
140. Zhan Q., Lord K.A., Alamo I., Hollander M.C., Carrier F., Ron D., Kohn K.W., Hoffman B., Liebermann D.A., Fornace A.J. Jr. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol. Cell. Biol. 14:1994a;2361-2371.
141. Zhan Q., Fan S., Bae I., Guillouf C., Liebermann D.A., O'Connor P.M., Fornace A.J. Jr. Induction of BAX by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene. 9:1994b;3743-3751.
142. Zhan Q., El-Deiry W.S., Bae I., Alamo I., Kastan M.B., Vogelstein B., Fornace A.J. Jr. Similarity of the DNA-damage responsiveness and growth-suppressive properties of WAF1/CIP1 and GADD45. Int. J. Oncology. 6:1995;937-946.
143. Zhou M., Yeager A.M., Smith S.D., Findley H.W. Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood. 85:1995;1608-1614.